XClose

The Comprehensive Clinical Trials Unit at UCL

Home
Menu

Current trials

A full list of all our current trials, including open and recruiting trials, as well as closed to recruitment, in follow up and analysis.

 

All

ADEPT-PD

Antidepressants in Parkinson's Disease.

ASEPTIC

Primary Antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis.

COG-UK HOCI

A phase III prospective, interventional, cohort, superiority study to evaluate the benefit of rapid COVID-19 genomic sequencing (the COVID-19 GENOMICS UK project) on infection control in preventing the spread of the virus in United Kingdom NHS settings.

CROWN CORONATION

International, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate interventions in preventing COVID-19 disease in adults.

DESPIAD

Depletion of serum Amyloid P Component in Alzheimer's Disease.

EVERREST

Developing a therapy for Fetal Growth Restriction.

EXENATIDE-PD3

A randomised, double blind, parallel group, placebo controlled Phase 3 trial of Exenatide once weekly over 2 years as a potential disease modifying treatment for Parkinson's disease.

FLARE

Favipiravir +/- Lopinavir: A RCT of Early antivirals

HORACE

Phase I/II open label, multicentre clinical trial to assess the safety and efficacy of ssAAV-LK03.hAAT.hcoOTC (Gene Therapy) for paediatric patients with ornithine transcarbamylase deficiency.

METRIC

Magnetic resonance Enterography (MRE) or ulTRasound In Crohn’s disease Extended Follow-up for predicting disabling disease.

MICE

Integrating Care for young people with epilepsy.

MINIMISE

Mycophenolate in limited cutaneous systemic sclerosis

MOTILITY

MRI for early response prediction to anti-TNF therapy.

MS-STAT2

MS-STAT2 : Multiple Sclerosis - Simvastatin Trial 2.

OPTIMAS

OPtimal TIMing of Anticoagulation after Stroke

RAFT

First in Human Phase I/II Clinical Trial of RAFT for Aniridia Related Keratopathy.

RESPONSE

Phase 1 safety study of Recombinant Surfactant Protein D to prevent neonatal Chronic Lung Disease (nCLD) in preterm infants.

RISAPS

A prospective randomised controlled phase II clinical trial of rivaroxaban versus warfarin in stroke patients with antiphospholipid syndrome, with or without SLE.

A

ADEPT

Antidepressants in Parkinson's Disease.

ASEPTIC

Primary Antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis.

B

 

 

C

COG-UK HOCI

A phase III prospective, interventional, cohort, superiority study to evaluate the benefit of rapid COVID-19 genomic sequencing (the COVID-19 GENOMICS UK project) on infection control in preventing the spread of the virus in United Kingdom NHS settings.

CROWN CORONATION

Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION.

D

DESPIAD

Depletion of serum Amyloid P Component in Alzheimer's Disease.

E

EVERREST

Developing a therapy for Fetal Growth Restriction.

EXENATIDE-PD3

A randomised, double blind, parallel group, placebo controlled Phase 3 trial of Exenatide once weekly over 2 years as a potential disease modifying treatment for Parkinson's disease.

F

FLARE

Favipiravir +/- Lopinavir: A RCT of Early antivirals

G

 

H

HORACE

Phase I/II open label, multicentre clinical trial to assess the safety and efficacy of ssAAV-LK03.hAAT.hcoOTC (Gene Therapy) for paediatric patients with ornithine transcarbamylase deficiency.

I

 

J

 

K

 

L

 

 

M

METRIC

Magnetic resonance Enterography (MRE) or ulTRasound In Crohn’s disease Extended Follow-up for predicting disabling disease.

MICE

Integrating Care for young people with epilepsy.

MINIMISE

Mycophenolate in limited cutaneous systemic sclerosis

MOTILITY

MRI for early response prediction to anti-TNF therapy.

MS-STAT2

MS-STAT2 : Multiple Sclerosis - Simvastatin Trial 2.

N

 

O

OPTIMAS

OPtimal TIMing of Anticoagulation after Stroke

P

 

Q

 

R

RAFT

First in Human Phase I/II Clinical Trial of RAFT for Aniridia Related Keratopathy.

RESPONSE

Phase 1 safety study of Recombinant Surfactant Protein D to prevent neonatal Chronic Lung Disease (nCLD) in preterm infants.

RISAPS

A prospective randomised controlled phase II clinical trial of rivaroxaban versus warfarin in stroke patients with antiphospholipid syndrome, with or without SLE.

S

 

T

 

U

 

V

 

W

 

X

 

Y

 

Z